These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23013048)

  • 1. Evaluation of gustatory function in HIV-infected subjects with and without HAART.
    Raja JV; Rai P; Khan M; Banu A; Bhuthaiah S
    J Oral Pathol Med; 2013 Mar; 42(3):216-21. PubMed ID: 23013048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of gustatory function in patients with diabetes mellitus type 2.
    Gondivkar SM; Indurkar A; Degwekar S; Bhowate R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):876-80. PubMed ID: 19913725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taste intensity and hedonic responses to simple beverages in gastrointestinal cancer patients.
    Bossola M; Cadoni G; Bellantone R; Carriero C; Carriero E; Ottaviani F; Borzomati D; Tortorelli A; Doglietto GB
    J Pain Symptom Manage; 2007 Nov; 34(5):505-12. PubMed ID: 17616339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral lesions in Brazilian HIV-infected children undergoing HAART.
    Miziara ID; Filho BC; Weber R
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology, diagnostic and therapeutic management of taste disorders].
    Welge-Lüssen A; Gudziol H
    Ther Umsch; 2004 May; 61(5):302-7. PubMed ID: 15195715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy.
    Chitra P; Bakthavatsalam B; Palvannan T
    Clin Chim Acta; 2011 May; 412(11-12):1151-4. PubMed ID: 21300045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the factors involving in the development of hypothyroidism in HIV-infected patients: a case-control study.
    Afhami S; Haghpanah V; Heshmat R; Rasoulinejad M; Izadi M; Lashkari A; Tavangar SM; Hajiabdolbaghi M; Mohraz M; Larijani B
    Infection; 2007 Oct; 35(5):334-8. PubMed ID: 17885731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of Qt and a-vO2 in individuals with HIV taking and not taking HAART.
    Cade WT; Fantry LE; Nabar SR; Shaw DK; Keyser RE
    Med Sci Sports Exerc; 2003 Jul; 35(7):1108-17. PubMed ID: 12840630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculatory vascular dysfunction in HIV-1 infected patients receiving highly active antiretroviral therapy.
    Palios J; Ikonomidis I; Lekakis J; Tsiodras S; Poulakou G; Antoniadou A; Panagopoulos P; Papadopoulos A; Giamarellou H; Anastasiou-Nana M; Kremastinos D
    Microcirculation; 2010 May; 17(4):303-10. PubMed ID: 20536743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and recognition thresholds to the 4 basic tastes in Mexican patients with primary Sjögren's syndrome.
    Gomez FE; Cassís-Nosthas L; Morales-de-León JC; Bourges H
    Eur J Clin Nutr; 2004 Apr; 58(4):629-36. PubMed ID: 15042131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.